majors still trying to cap

As I have been saying, the major s/holder, and others close have been accumulating this stock, major leap forwards in the offing, every other company involved in this field, has in the past, been taken out and or sat on by the major US Pharma,s, hence the capping and the Jagen influence.

EIF is a prime target for t/over, as they are the most advanced and also have the full suite of processes yet developed, but not at these prices, I believe the market has been waiting for someone to show their hand here, which shortly should be revealed